Omeros said all the six patients, who needed mechanical ventilation before treatment, recovered and were discharged from hospital. COVID-19 patients with ARDS often require intensive care. Omeros' treatment, narsoplimab, is a human monoclonal antibody that recognises and locks onto a virus, preventing the infection from spreading. The company said it was in talks with the US government for potential funding to speed up large-scale manufacturing of narsoplimab. A manuscript detailing the results of the study has been accepted for publication in the peer-reviewed journal Immunobiology, Omeros said.

Source: bd News24 August 10, 2020 12:45 UTC